Cannabis Stock Gainers And Losers From Nov. 19, 2019

Gainers

• Aurora Cannabis ACB shares gained 2.63%, closing at $2.34.
• Aphria APHA shares rose 12.3%, to close at $4.29.
• Columbia Care CCHWF shares gained 2.96%, closing at $2.60.
• Canopy Growth CGC shares gained 7.63%, closing at $15.30.
• Cronos Group CRON shares rose 9.12%, to close at $6.70.
• CannTrust Holdings CTST shares increased by 6.4% to close at $0.85.
• Fire & Flower Holdings FFLWF shares rose 6.29%, to close at $0.66.
• GW Pharmaceuticals GWPH shares increased by 1.06% to close at $103.56.
• HEXO HEXO shares increased by 15.09% to close at $1.83.
• KushCo Holdings KSHB shares rose 11.56%, to close at $1.64.
• MediPharm Labs MEDIF shares gained 1.67%, closing at $3.05.
• OrganiGram Holdings OGI shares rose 12.62%, to close at $2.32.
• Planet 13 Holdings PLNHF shares rose 0.09%, to close at $1.50.
• Sundial Growers SNDL shares increased by 2.49% to close at $2.88.
• Supreme Cannabis Co SPRWF shares gained 5.19%, closing at $0.49.
• Tilray TLRY shares rose 0.35%, to close at $19.98.
• Therapix Biosciences TRPX shares rose 11.56%, to close at $1.64 after announcing its intent to pursue a reverse merger with Heavenly Rx.
• Valens Groworks VGWCF shares gained 0.85%, closing at $2.37.
• Zynerba Pharmaceuticals ZYNE shares rose 3.4%, to close at $6.38.

Losers

• Cresco Labs CRLBF shares dropped by 0.33%, to close at $5.73.
• Greenlane Holdings GNLN shares fell 2.48% to close at $3.54.
• Harvest Health HRVSF shares tumbled by 3.63%, eventually closing at $2.55.
• Innovative Industrial IIPR shares tumbled by 0.12%, eventually closing at $82.74.
• Akerna KERN shares dropped by 3.45%, to close at $5.03.
• Alcanna LQSIF shares tumbled by 4.34%, eventually closing at $2.93.
• MedMen Enterprises MMNFF shares dropped by 14.24%, to close at $0.65.
• Pyxus International PYX shares fell 0.92% to close at $7.53.
• cbdMD YCBD shares tumbled by 6.98%, eventually closing at $3.20.

Related Links:

Trulieve Reports Record Q3 Revenue

Ayr Strategies Reports Q3 Earnings, Projects Double Adjusted EBITDA In 2020